Scientists push for standardized data rules to speed up drug safety testing

Researchers say toxicity pathways used to replace animal testing need consistent formatting and shared access to work effectively. The move could accelerate how quickly regulators and pharma companies can evaluate drug safety—and cut costs by better organizing scattered research data.

Originaltitel: Why Adverse Outcome Pathways Need to be FAIR